Published in HIV Med on August 21, 2008
Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev (2010) 9.82
Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet (2010) 3.90
Predictors of mortality in Staphylococcus aureus Bacteremia. Clin Microbiol Rev (2012) 2.18
Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev (2015) 1.94
Association of methicillin-resistant Staphylococcus aureus (MRSA) USA300 genotype with mortality in MRSA bacteremia. J Infect (2010) 1.12
Community-associated methicillin-resistant Staphylococcus aureus bacteremia and endocarditis among HIV patients: a cohort study. BMC Infect Dis (2011) 0.95
Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus colonization in HIV infection: a meta-analysis. Clin Infect Dis (2014) 0.88
Recurrent community-acquired methicillin-resistant Staphylococcus aureus infections in an HIV-infected person. J Clin Microbiol (2011) 0.86
Methicillin-resistant Staphylococcus aureus in HIV-infected patients. Infect Drug Resist (2010) 0.86
Skin and soft tissue infections among HIV-infected persons in the late combination antiretroviral therapy era. Int J STD AIDS (2012) 0.82
Bloodstream infections in HIV-infected patients. Virulence (2016) 0.78
Methicillin-resistant Staphylococcus aureus in HIV patients: risk factors associated with colonization and/or infection and methods for characterization of isolates - a systematic review. Clinics (Sao Paulo) (2014) 0.77
Etiologic Agents of Bacterial Sepsis and Their Antibiotic Susceptibility Patterns among Patients Living with Human Immunodeficiency Virus at Gondar University Teaching Hospital, Northwest Ethiopia. Biomed Res Int (2016) 0.75
Prevalence and risk factors of methicillin-resistant Staphylococcus aureus colonization among HIV patients in Mekelle, Northern Ethiopia. Springerplus (2016) 0.75
National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control (2004) 14.85
The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis (1983) 10.03
Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J (2004) 4.58
Community-acquired bacteremia in patients with acquired immunodeficiency syndrome: clinical presentation, bacteriology, and outcome. Am J Med (1989) 2.58
Population dynamics of nasal strains of methicillin-resistant Staphylococcus aureus--and their relation to community-associated disease activity. J Infect Dis (2005) 2.34
EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol (1998) 2.08
Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. J Infect Dis (2001) 2.04
Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia. Arch Intern Med (2000) 1.97
Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men. Clin Infect Dis (2005) 1.97
Increased incidence of Staphylococcus aureus bacteremia in hospitalized patients with acquired immunodeficiency syndrome. Clin Infect Dis (2001) 1.70
Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. J Acquir Immune Defic Syndr (2005) 1.47
Bacteremia in hospitalized patients infected with the human immunodeficiency virus: a case-control study of risk factors and outcome. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.47
Staphylococcus aureus bacteremia and recurrent staphylococcal infection in patients with acquired immunodeficiency syndrome and AIDS-related complex. Am J Med (1988) 1.44
Bacteremia and fungemia in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1986) 1.35
Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med (1999) 1.32
Increased rate of carriage of Staphylococcus aureus among narcotic addicts. J Infect Dis (1974) 1.24
Community-onset methicillin-resistant Staphylococcus aureus in an urban HIV clinic. HIV Med (2006) 1.22
Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients. J Antimicrob Chemother (2002) 1.09
Risk factors for recurrence in patients with Staphylococcus aureus infections complicated by bacteremia. Diagn Microbiol Infect Dis (2006) 1.05
Risk factors for methicillin-resistance among patients with Staphylococcus aureus bacteremia at the time of hospital admission. Am J Med Sci (2002) 0.98
Staphylococcus aureus colonization in a community sample of HIV-infected and HIV-uninfected drug users. Eur J Clin Microbiol Infect Dis (2003) 0.96
A series of skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus in HIV-infected patients. J Acquir Immune Defic Syndr (2006) 0.94
Risk factors for hospital-acquired methicillin-resistant Staphylococcus aureus bacteraemia: a case-control study. Epidemiol Infect (2006) 0.93
Community-onset healthcare-associated MRSA bacteraemia in a district general hospital. J Hosp Infect (2006) 0.82
Spectrum of bacterial isolates in HIV-positive patients with skin and soft tissue infections: emergence of methicillin-resistant Staphylococci. AIDS (2003) 0.79
Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med (1995) 13.59
Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA (2001) 10.63
The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA (2000) 7.65
Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med (2001) 7.14
Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis (1987) 5.63
Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med (1999) 5.05
Self-reported antiretroviral therapy in injection drug users. JAMA (1998) 4.75
Clostridium difficile colitis: an efficient clinical approach to diagnosis. Ann Intern Med (1995) 4.42
The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med (2001) 4.12
Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. J Acquir Immune Defic Syndr (2001) 3.67
Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. J Infect Dis (1992) 3.61
Race, sex, drug use, and progression of human immunodeficiency virus disease. N Engl J Med (1995) 3.44
Sink or swim: strategies for cost-efficient diving by marine mammals. Science (2000) 3.40
Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia. Blood (1992) 3.09
Net costs from three perspectives of using low versus high osmolality contrast medium in diagnostic angiocardiography. J Am Coll Cardiol (1993) 2.72
The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial. Health Technol Assess (2008) 2.68
Long-term azithromycin may improve lung function in children with cystic fibrosis. Lancet (1998) 2.66
Knowledge, attitudes, and reported practices of medical students and house staff regarding the diagnosis and treatment of alcoholism. JAMA (1989) 2.56
Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia. Am J Med (1984) 2.54
Potential factors affecting adherence with HIV therapy. AIDS (1997) 2.44
The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia. J Infect Dis (1984) 2.44
Characteristics, diagnosis, and treatment of alcoholism in elderly patients. J Am Geriatr Soc (1989) 2.43
Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Arch Gen Psychiatry (2000) 2.34
Association of initial CD4 cell count and viral load with response to highly active antiretroviral therapy. JAMA (2000) 2.25
Moderate alcohol consumption and coronary artery disease. A review. Medicine (Baltimore) (1986) 2.22
A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users. Am J Med (2001) 2.15
Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group. JAMA (1991) 2.08
Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus. Clin Infect Dis (1995) 2.01
31P NMR studies of intracellular free Mg2+ in intact frog skeletal muscle. J Biol Chem (1980) 2.01
NMR studies of intracellular metal ions in intact cells and tissues. Annu Rev Biophys Bioeng (1984) 1.97
Cryptosporidiosis in patients with AIDS: correlates of disease and survival. Clin Infect Dis (1998) 1.97
Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Medicine (Baltimore) (1996) 1.90
Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.89
Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy. AIDS (2001) 1.88
Prophylaxis for opportunistic infections in patients with HIV infection. Ann Intern Med (1994) 1.87
Pre-pregnancy body mass index and pregnancy outcomes. Int J Gynaecol Obstet (2006) 1.84
Hypertension and its treatment in postmenopausal women: baseline data from the Women's Health Initiative. Hypertension (2000) 1.77
Hazardous drinking is associated with an elevated aspartate aminotransferase to platelet ratio index in an urban HIV-infected clinical cohort. HIV Med (2008) 1.74
Immune responses to AAV in a phase I study for Canavan disease. J Gene Med (2006) 1.74
Impact of opportunistic disease on survival in patients with HIV infection. AIDS (1998) 1.71
Alcohol abuse: comparison of two methods for assessing its prevalence and associated morbidity in hospitalized patients. Am J Med (1991) 1.66
Predictors of outpatient treatment retention: patient versus substance use characteristics. Drug Alcohol Depend (2001) 1.60
HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy. AIDS (2001) 1.60
The effect of adjunctive corticosteroids for the treatment of Pneumocystis carinii pneumonia on mortality and subsequent complications. Chest (1998) 1.58
Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients. J Infect Dis (1996) 1.58
Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med (1984) 1.57
Implications for macrolide treatment in community-acquired pneumonia. Hopkins CAP Team. Chest (1998) 1.57
The impact of prophylaxis on outcome and resource utilization in Pneumocystis carinii pneumonia. Chest (1995) 1.53
Risk factors for the development of auditory toxicity in patients receiving aminoglycosides. J Infect Dis (1984) 1.52
Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients. HIV Med (2005) 1.49
The impact of illicit drug use and substance abuse treatment on adherence to HAART. AIDS Care (2007) 1.48
A pilot study of peer review in residency training. J Gen Intern Med (1999) 1.47
Prevention of opportunistic infections in the era of improved antiretroviral therapy. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.46
Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis (1998) 1.45
Lack of association between acyclovir use and survival in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group. J Infect Dis (1995) 1.45
To clip or not to clip? Noseclips for spirometry. Eur Respir J (2003) 1.44
The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults. J Infect Dis (1998) 1.40
Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography. N Engl J Med (1992) 1.40
Breastfeeding and severe maternal pain. J Hum Lact (1997) 1.39
Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology. Clin Infect Dis (1997) 1.38
Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. Am Rev Respir Dis (1992) 1.38
The sensitivity and specificity of various tuberculin tests using bovine PPD and other tuberculins. Vet Rec (1978) 1.37
Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2001) 1.36
Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients with advanced HIV infection. Am J Respir Crit Care Med (2000) 1.35
Costs of HIV medical care in the era of highly active antiretroviral therapy. AIDS (1999) 1.33
Design of the multicenter study of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea. Control Clin Trials (1995) 1.32
Delayed hatching of salamander eggs in response to enhanced larval predation risk. Am Nat (1993) 1.31
Community-acquired pneumonia: impact of immune status. Am J Respir Crit Care Med (1995) 1.29
Stimulation of Na:H exchange by insulin. Biophys J (1981) 1.28
Bacteroides fragilis toxin exhibits polar activity on monolayers of human intestinal epithelial cells (T84 cells) in vitro. Infect Immun (1997) 1.26
Effects of insulin upon ion transport. Biochim Biophys Acta (1983) 1.25
Hepatomegaly and steatosis in HIV-infected patients receiving nucleoside analog antiretroviral therapy. Am J Gastroenterol (1995) 1.24
Use of complementary and alternative medicines among a multistate, multisite cohort of people living with HIV/AIDS. HIV Med (2007) 1.21
Menstrual Hypoglycemia and Functional Dysmenorrhea: Their Relationship. Cal West Med (1936) 1.16
Emergency department utilization among HIV-infected patients in a multisite multistate study. HIV Med (2009) 1.15
Social integration and black intraracial variation in blood pressure. Ethn Dis (1991) 1.15
Disulfiram treatment of alcoholism. Am J Med (1990) 1.15
Lessons learned from the design and implementation of myocardial infarction adjudication tailored for HIV clinical cohorts. Am J Epidemiol (2014) 1.14
A clinicopathologic analysis of AIDS-related cryptosporidiosis. AIDS (1998) 1.14
Time dependency of cognitive recovery with cobalamin replacement: report of a pilot study. J Am Geriatr Soc (1992) 1.14
Intracellular pH mediates action of insulin on glycolysis in frog skeletal muscle. Am J Physiol (1982) 1.13
Effect of insulin upon the sodium pump in frog skeletal muscle. J Physiol (1973) 1.13
Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonist. J Pharmacol Exp Ther (1987) 1.11
Effects of an incentive and education program on return rates for PPD test reading in patients with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.11
Cryptosporidiosis in northeastern Brazilian children: association with increased diarrhea morbidity. J Infect Dis (1998) 1.09
Emotion recognition in schizophrenia: further investigation of generalized versus specific deficit models. J Abnorm Psychol (2000) 1.08
Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent. Crit Care Med (1999) 1.07
Effect of insulin upon membrane-bound (Na+ + K+)-ATPase extracted from frog skeletal muscle. J Physiol (1975) 1.07
Child sexual abuse. Aust Fam Physician (1988) 1.07
Estimating the potential pool of HIV-infected deceased organ donors in the United States. Am J Transplant (2011) 1.07
Single-dose pharmacokinetic and pharmacodynamic comparison of polymer-matrix (Slow Trasicor) and Oros dosage forms of oxprenolol in healthy volunteers. Br J Clin Pharmacol (1985) 1.05
Contraceptive outcomes among post-partum and post-abortal adolescents. Contraception (1994) 1.03
Phylogenetic relationships within the eared seals (Otariidae: Carnivora): implications for the historical biogeography of the family. Mol Phylogenet Evol (2001) 1.03
Lister strain of vaccinia virus armed with endostatin-angiostatin fusion gene as a novel therapeutic agent for human pancreatic cancer. Gene Ther (2009) 1.02
A model for predicting nephrotoxicity in patients treated with aminoglycosides. J Infect Dis (1986) 1.01
Relative contributions of intestinal, gastric, oro-sensory influences and information to changes in appetite induced by the same liquid meal. Appetite (1998) 1.01
Functional status of persons with HIV infection in an ambulatory setting. J Acquir Immune Defic Syndr (1994) 1.00